BRAF and melanoma: It should be noted that earlier studies found that metformin could be accelerating growth of NRAS mutant cell lines, and that vemurafenib could have antagonistic effect in some BRAF mutant melanoma cell lines, in particular those that are resistant to vemurafenib [154, 155]